Document:

Exhibit 10.4

 

Employment Agreement

 

This
Employment Agreement (the “Agreement”) is made and entered into as of February 25, 2015, by and between Dr.
Raouf Guirguis (the “Executive”) and Unique Growing Solutions, Inc. (f/k/a Alternative Energy & Environmental
Solutions, Inc.), a Nevada corporation (the “Company”).

 

WHEREAS,
the Company desires to employ the Executive on the terms and conditions set forth herein; and

 

WHEREAS,
the Executive desires to be employed by the Company on such terms and conditions.

 

NOW,
THEREFORE, in consideration of the mutual covenants, promises and obligations set forth herein, the parties agree as follows:

  

1.  Term  The
Executive’s employment hereunder shall be effective as of February 26, 2015 (the “Effective Date”) and
shall continue until the third anniversary thereof, unless terminated earlier pursuant to Section 4 of this Agreement; provided
that, on such third anniversary of the Effective Date and each annual anniversary thereafter (such date and each annual anniversary
thereof, a “Renewal Date”), the Agreement shall be deemed to be automatically extended, upon the same terms
and conditions, for successive periods of one year, unless either party provides written notice of its intention not to extend
the term of the Agreement at least sixty (60) days prior to the applicable Renewal Date. The period during which the Executive
is employed by the Company hereunder is hereinafter referred to as the “Employment Term”.

 

2.  Position
and Duties  

  

2.1.  Position  During
the Employment Term, the Executive shall serve as the Chief Executive Officer of the Company. In such position, the Executive
shall have such duties, authority and responsibility as shall be determined from time to time by the board of directors of the
Company (the “Board”), which duties, authority and responsibility are consistent with the Executive’s
position. One of the duties of the Executive shall be to continue his ongoing research and development of the technology that
enables diagnosing illness in humans via a saliva test. The Executive shall also serve as a member of the Board for no additional
compensation.

 

2.2.  Duties  During
the Employment Term, the Executive shall devote substantially all of his business time and attention to the performance of the
Executive’s duties hereunder and will not engage in any other business, profession or occupation for compensation or otherwise
which would conflict or interfere with the performance of such services either directly or indirectly without the prior unanimous
written consent of the Board. Notwithstanding the foregoing, the Executive will be permitted to purchase or own less than five
percent (5%) of the publicly traded securities of any corporation; provided that, such ownership represents a passive investment
and that the Executive is not a controlling person of, or a member of a group that controls, such corporation; provided further
that such ownership does not interfere with the performance of the Executive’s duties and responsibilities to the Company
as provided hereunder, including, but not limited to, the obligations set forth in Section 2 hereof.

 

    	1

    	 

    

 

3.  Compensation  

 

3.1.  Base
Salary  The Company shall pay the Executive an annual rate of base salary of $350,000 in periodic installments in
accordance with the Company’s customary payroll practices. The Executive’s annual base salary, as in effect from time
to time, is hereinafter referred to as “Base Salary”.

 

3.2.  Stock
Issuance Signing Bonus  The Company shall issue to the Executive thirty seven million, five hundred thousand shares (37,500,000)
of common stock of the Company (the “Stock Issuance Signing Bonus”) within twenty (20) days following the Effective
Date.

 

3.3.  Business
Expenses  The Executive shall be entitled to reimbursement for all reasonable and necessary out-of-pocket business,
entertainment, and travel expenses incurred by the Executive in connection with the performance of the Executive’s duties
hereunder in accordance with the Company’s expense reimbursement policies and procedures.

 

3.4.  Indemnification  

  

(a)  In
the event that the Executive is made a party or threatened to be made a party to any action, suit, or proceeding, whether civil,
criminal, administrative or investigative (a “Proceeding”), other than any Proceeding initiated by the Executive
or the Company related to any contest or dispute between the Executive and the Company or any of its affiliates with respect to
this Agreement or the Executive’s employment hereunder, by reason of the fact that the Executive is or was a director or
officer of the Company, or any affiliate of the Company, or is or was serving at the request of the Company as a director, officer,
member, employee or agent of another corporation or a partnership, joint venture, trust or other enterprise, the Executive shall
be indemnified and held harmless by the Company to the maximum extent permitted under applicable law and the Company’s bylaws
from and against any liabilities, costs, claims and expenses, including all costs and expenses incurred in defense of any Proceeding
(including attorneys’ fees). 

 

(b)  During
the Employment Term, the Company or any successor to the Company shall purchase and maintain, at its own expense, directors’
and officers’ liability insurance providing coverage to the Executive on terms that are no less favorable than the coverage
provided to other directors and similarly situated executives of the Company.

 

4.  Termination
of Employment  

 

The
Employment Term and the Executive’s employment hereunder may be terminated by either the Company or the Executive at any
time and for any reason; provided that, unless otherwise provided herein, either party shall be required to give the other party
at least thirty (30) days advance written notice of any termination of the Executive’s employment. Upon termination of the
Executive’s employment during the Employment Term, the Executive shall be entitled to the compensation and benefits described
in this Section 4 and shall have no further rights to any compensation or any other benefits from the Company or any of its affiliates.

 

    	2

    	 

    

 

4.1.  
Expiration of the Term, for Cause, or Without Good Reason  

 

(a)  The
Executive’s employment hereunder may be terminated upon either party’s failure to renew the Agreement in accordance
with Section 1, by the Company for Cause (as defined below), or by the Executive without Good Reason (as defined below). If the
Executive’s employment is terminated upon either party’s failure to renew the Agreement, by the Company for Cause
or by the Executive without Good Reason, the Executive shall be entitled to receive:

 

(i)
any accrued but unpaid Base Salary which shall be paid within twenty (20) days following the Termination Date (as defined below);
and

 

(ii)
reimbursement for unreimbursed business expenses properly incurred by the Executive, which shall be subject to and paid in accordance
with the Company’s expense reimbursement policy

 

Items
4.1(a)(i) through 4.1(a)(iiv) are referred to herein collectively as the “Accrued Amounts”.

 

(b)  For
purposes of this Agreement, “Cause” shall mean:

 

(i)
the Executive’s failure to perform his duties (other than any such failure resulting from incapacity due to physical or
mental illness);

 

(ii)
the Executive’s engagement in dishonesty, illegal conduct or gross misconduct, which is, in each case, injurious to the
Company or its affiliates;

 

(iii)
the Executive’s embezzlement, misappropriation or fraud, whether or not related to the Executive’s employment with
the Company;

 

(iv)
the Executive’s conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state
law equivalent);

 

(v)
the Executive’s willful unauthorized disclosure of Confidential Information (as defined below); or

 

(vi) the Executive’s
material breach of any material obligation under this Agreement or any other written agreement between the Executive and the Company.

 

Termination
of the Executive’s employment shall not be deemed to be for Cause unless and until the Company delivers to the Executive
a copy of a resolution duly adopted by the affirmative vote of not less than a majority of the Board (not including the Executive
if he is a member of the Board), finding that the Executive has engaged in the conduct described in any of (i)-(vi) above.

 

    	3

    	 

    

 

(c)  For
purposes of this Agreement, “Good Reason” shall mean the occurrence of any of the following, in each case during
the Employment Term without the Executive’s written consent:

 

(i)
a material reduction in the Executive’s Base Salary other than a general reduction in Base Salary that affects all similarly
situated executives in substantially the same proportions; or

 

(ii)
the Company’s failure to obtain an agreement from any successor to the Company to assume and agree to perform this Agreement
in the same manner and to the same extent that the Company would be required to perform if no succession had taken place, except
where such assumption occurs by operation of law;

 

The
Executive cannot terminate his employment for Good Reason unless he has provided written notice to the Company of the existence
of the circumstances providing grounds for termination for Good Reason within five (5) days of the initial existence of such grounds
and the Company has had at least ten (10) days from the date on which such notice is provided to cure such circumstances. If the
Executive does not terminate his employment for Good Reason within fifteen (15) days after the first occurrence of the applicable
grounds, then the Executive will be deemed to have waived his right to terminate for Good Reason with respect to such grounds.

 

4.2.  
Without Cause or for Good Reason  

 

The
Employment Term and the Executive’s employment hereunder may be terminated by the Executive for Good Reason or by the Company
without Cause. In the event of such termination, the Executive shall be entitled to receive the Accrued Amounts and subject to
the Executive’s compliance with Sections 5 and 6 of this Agreement and his execution of a release of claims in favor of
the Company, its affiliates and their respective officers and directors in a form provided by the Company (the “Release”)
and such Release becoming effective within five (5) days following the Termination Date (such five-day period, the “Release
Execution Period”), the Executive shall be entitled to receive continued Base Salary for one year following the
Termination Date payable in equal installments in accordance with the Company’s normal payroll practices, but no less frequently
than monthly, which shall commence within sixty (60) days following the Termination Date; provided that, the first installment
payment shall include all amounts of Base Salary that would otherwise have been paid to the Executive during the period beginning
on the Termination Date and ending on the first payment date if no delay had been imposed;

 

4.3.  Death
or Disability  

 

(a)  The
Executive’s employment hereunder shall terminate automatically upon the Executive’s death during the Employment Term,
and the Company may terminate the Executive’s employment on account of the Executive’s Disability.

 

(b)  If
the Executive’s employment is terminated during the Employment Term on account of the Executive’s death or Disability,
the Executive (or the Executive’s estate and/or beneficiaries, as the case may be) shall be entitled to receive the Accrued
Amounts. Notwithstanding any other provision contained herein, all payments made in connection with the Executive’s Disability
shall be provided in a manner which is consistent with federal and state law.

 

    	4

    	 

    

 

(c)  For
purposes of this Agreement, Disability shall mean the Executive’s inability, due to physical or mental incapacity, to substantially
perform his duties and responsibilities under this Agreement for one hundred twenty (120) days out of any three hundred sixty-five
(365) day period; provided however, in the event the Company temporarily replaces the Executive, or transfers the Executive’s
duties or responsibilities to another individual on account of the Executive’s inability to perform such duties due to a
mental or physical incapacity which is, or is reasonably expected to become, a Disability, then the Executive’s employment
shall not be deemed terminated by the Company. Any question as to the existence of the Executive’s Disability as to which
the Executive and the Company cannot agree shall be determined in writing by a qualified independent physician mutually acceptable
to the Executive and the Company. If the Executive and the Company cannot agree as to a qualified independent physician, each
shall appoint such a physician and those two physicians shall select a third who shall make such determination in writing. The
determination of Disability made in writing to the Company and the Executive shall be final and conclusive for all purposes of
this Agreement.

 

4.4.  Notice
of Termination  Any termination of the Executive’s employment hereunder by the Company or by the Executive
during the Employment Term (other than termination pursuant to Section 4.3(a) on account of the Executive’s death) shall
be communicated by written notice of termination (“Notice of Termination”) to the other party hereto in accordance
with Section 14. The Notice of Termination shall specify:

 

(a)  The
termination provision of this Agreement relied upon;

 

(b)  To
the extent applicable, the facts and circumstances claimed to provide a basis for termination of the Executive’s employment
under the provision so indicated; and

 

(c)  The
applicable Termination Date.

 

4.5.  Termination
Date  The Executive’s Termination Date shall be:

 

(a)  If
the Executive’s employment hereunder terminates on account of the Executive’s death, the date of the Executive’s
death;

 

(b)  If
the Executive’s employment hereunder is terminated on account of the Executive’s Disability, the date that it is determined
that the Executive has a Disability;

 

(c)  If
the Company terminates the Executive’s employment hereunder for Cause, the date the Notice of Termination is delivered to
the Executive;

 

(d)  If
the Company terminates the Executive’s employment hereunder without Cause, the date specified in the Notice of Termination,
which shall be no less than five (5) days following the date on which the Notice of Termination is delivered;

 

    	5

    	 

    

 

(e)  If
the Executive terminates his employment hereunder with or without Good Reason, the date specified in the Executive’s Notice
of Termination, which shall be no less than five (5) days following the date on which the Notice of Termination is delivered;
and

 

(f)  If
the Executive’s employment hereunder terminates because either party provides notice of non-renewal pursuant to Section
1, the Renewal Date immediately following the date on which the applicable party delivers notice of non-renewal.

 

4.6.  Resignation
of All Other Positions  Upon termination of the Executive’s employment hereunder for any reason, the Executive
shall be deemed to have resigned from all positions that the Executive holds as an officer or member of the Board (or a committee
thereof) of the Company or any of its affiliates.

 

5.  Cooperation  The
parties agree that certain matters in which the Executive will be involved during the Employment Term may necessitate the Executive’s
cooperation in the future. Accordingly, following the termination of the Executive’s employment for any reason, to the extent
reasonably requested by the Board, the Executive shall cooperate with the Company in connection with matters arising out of the
Executive’s service to the Company; provided that, the Company shall make reasonable efforts to minimize disruption of the
Executive’s other activities. The Company shall reimburse the Executive for reasonable expenses incurred in connection with
such cooperation and, to the extent that the Executive is required to spend substantial time on such matters, the Company shall
compensate the Executive at an hourly rate based on the Executive’s Base Salary on the Termination Date.

 

6.  Confidential
Information  The Executive understands and acknowledges that during the Employment Term, he will have access to
and learn about Confidential Information, as defined below.

 

6.1.  Confidential
Information Defined  

 

(a)  Definition.

 

For
purposes of this Agreement, ”Confidential Information” includes, but is not limited to, all information not
generally known to the public, in spoken, printed, electronic or any other form or medium, relating directly or indirectly to:
business processes, practices, methods, documents, research, operations, agreements, contracts, terms of agreements, transactions,
potential transactions, negotiations, pending negotiations, know-how, trade secrets, manuals, records, articles, supplier information,
vendor information, financial information, results, accounting information, accounting records, legal information, payroll information,
staffing information, personnel information, employee lists, supplier lists, vendor lists, internal controls, sales information,
revenue, costs, of the Company or its businesses or any existing or prospective customer, supplier, investor or other associated
third party, or of any other person or entity that has entrusted information to the Company in confidence.

 

    	6

    	 

    

 

The
Executive understands that the above list is not exhaustive, and that Confidential Information also includes other information
that is marked or otherwise identified as confidential or proprietary, or that would otherwise appear to a reasonable person to
be confidential or proprietary in the context and circumstances in which the information is known or used.

 

The
Executive understands and agrees that Confidential Information includes information developed by him in the course of his employment
by the Company as if the Company furnished the same Confidential Information to the Executive in the first instance. Confidential
Information shall not include information that is generally available to and known by the public at the time of disclosure to
the Executive; provided that, such disclosure is through no direct or indirect fault of the Executive or person(s) acting on the
Executive’s behalf.

 

(b)  Disclosure
and Use Restrictions.

 

The
Executive agrees and covenants: (i) to treat all Confidential Information as strictly confidential; (ii) not to directly or indirectly
disclose, publish, communicate or make available Confidential Information, or allow it to be disclosed, published, communicated
or made available, in whole or part, to any entity or person whatsoever (including other employees of the Company) not having
a need to know and authority to know and use the Confidential Information in connection with the business of the Company and,
in any event, not to anyone outside of the direct employ of the Company except as required in the performance of the Executive’s
authorized employment duties to the Company acting on behalf of the Company in each instance (and then, such disclosure shall
be made only within the limits and to the extent of such duties); and (iii) not to access or use any Confidential Information,
and not to copy any documents, records, files, media or other resources containing any Confidential Information, or remove any
such documents, records, files, media or other resources from the premises or control of the Company, except as required in the
performance of the Executive’s authorized employment duties to the Company acting on behalf of the Company in each instance
(and then, such disclosure shall be made only within the limits and to the extent of such duties). Nothing herein shall be construed
to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid
order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the
extent of disclosure required by such law, regulation or order.

 

The
Executive understands and acknowledges that his obligations under this Agreement with regard to any particular Confidential Information
shall commence immediately upon the Executive first having access to such Confidential Information (whether before or after he
begins employment by the Company) and shall continue during and after his employment by the Company until such time as such Confidential
Information has become public knowledge other than as a result of the Executive’s breach of this Agreement or breach by
those acting in concert with the Executive or on the Executive’s behalf.

 

7.  Governing
Law: Jurisdiction and Venue  This Agreement, for all purposes, shall be construed in accordance with the laws of
Nevada without regard to conflicts of law principles. Any action or proceeding by either of the parties to enforce this Agreement
shall be brought only in a state or federal court located in the state of Nevada, city of Las Vegas. The parties hereby irrevocably
submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance of any such
action or proceeding in such venue.

 

    	7

    	 

    

 

8.  Entire
Agreement  Unless specifically provided herein, this Agreement contains all of the understandings and representations
between the Executive and the Company pertaining to the subject matter hereof and supersedes all prior and contemporaneous understandings,
agreements, representations and warranties, both written and oral, with respect to such subject matter. The parties mutually agree
that the Agreement can be specifically enforced in court and can be cited as evidence in legal proceedings alleging breach of
the Agreement.

 

9.  Modification
and Waiver  No provision of this Agreement may be amended or modified unless such amendment or modification is agreed
to in writing and signed by the Executive and by the Chief Financial Officer of the Company, or, if the Executive is the Chief
Financial Officer of the Company, a member of the Board of the Company whose only personal or business relationship to the Executive
is via working together in the affairs of the Company. No waiver by either of the parties of any breach by the other party hereto
of any condition or provision of this Agreement to be performed by the other party hereto shall be deemed a waiver of any similar
or dissimilar provision or condition at the same or any prior or subsequent time, nor shall the failure of or delay by either
of the parties in exercising any right, power or privilege hereunder operate as a waiver thereof to preclude any other or further
exercise thereof or the exercise of any other such right, power or privilege.

 

10.  Severability  Should
any provision of this Agreement be held by a court of competent jurisdiction to be enforceable only if modified, or if any portion
of this Agreement shall be held as unenforceable and thus stricken, such holding shall not affect the validity of the remainder
of this Agreement, the balance of which shall continue to be binding upon the parties with any such modification to become a part
hereof and treated as though originally set forth in this Agreement.

 

The
parties further agree that any such court is expressly authorized to modify any such unenforceable provision of this Agreement
in lieu of severing such unenforceable provision from this Agreement in its entirety, whether by rewriting the offending provision,
deleting any or all of the offending provision, adding additional language to this Agreement or by making such other modifications
as it deems warranted to carry out the intent and agreement of the parties as embodied herein to the maximum extent permitted
by law.

 

The
parties expressly agree that this Agreement as so modified by the court shall be binding upon and enforceable against each of
them. In any event, should one or more of the provisions of this Agreement be held to be invalid, illegal or unenforceable in
any respect, such invalidity, illegality or unenforceability shall not affect any other provisions hereof, and if such provision
or provisions are not modified as provided above, this Agreement shall be construed as if such invalid, illegal or unenforceable
provisions had not been set forth herein.

 

11.  Captions  Captions
and headings of the sections and paragraphs of this Agreement are intended solely for convenience and no provision of this Agreement
is to be construed by reference to the caption or heading of any section or paragraph.

 

12.  Counterparts  This
Agreement may be executed in separate counterparts, each of which shall be deemed an original, but all of which taken together
shall constitute one and the same instrument.

 

    	8

    	 

    

 

13.  Successors
and Assigns  This Agreement is personal to the Executive and shall not be assigned by the Executive. Any purported
assignment by the Executive shall be null and void from the initial date of the purported assignment. The Company may assign this
Agreement to any successor or assign (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially
all of the business or assets of the Company. This Agreement shall inure to the benefit of the Company and permitted successors
and assigns.

 

14.  Notice  Notices
and all other communications provided for in this Agreement shall be in writing and shall be delivered personally or sent by registered
or certified mail, return receipt requested, or by overnight carrier to the parties at addresses to be determined by the parties

 

15.  Representations
of the Executive  The Executive represents and warrants to the Company that:

 

15.1.  The
Executive’s acceptance of employment with the Company and the performance of his duties hereunder will not conflict with
or result in a violation of, a breach of, or a default under any contract, agreement or understanding to which he is a party or
is otherwise bound.

 

15.2.  The
Executive’s acceptance of employment with the Company and the performance of his duties hereunder will not violate any non-solicitation,
non-competition or other similar covenant or agreement of a prior employer.

 

16.  Withholding  The
Company shall have the right to withhold from any amount payable hereunder any Federal, state and local taxes in order for the
Company to satisfy any withholding tax obligation it may have under any applicable law or regulation.

 

17.  Survival  Upon
the expiration or other termination of this Agreement, the respective rights and obligations of the parties hereto shall survive
such expiration or other termination to the extent necessary to carry out the intentions of the parties under this Agreement.

 

    	9

    	 

    

 

18.  Acknowledgment
of Full Understanding  THE EXECUTIVE ACKNOWLEDGES AND AGREES THAT HE HAS FULLY READ, UNDERSTANDS AND VOLUNTARILY
ENTERS INTO THIS AGREEMENT. THE EXECUTIVE ACKNOWLEDGES AND AGREES THAT HE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT
WITH AN ATTORNEY OF HIS CHOICE BEFORE SIGNING THIS AGREEMENT.

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

	 	UNIQUE
                                         GROWING SOLUTIONS, INC.

        (F/K/A
        ALTERNATIVE ENERGY &

ENVIRONMENTAL SOLUTIONS, INC.) 

	 	 	 
	 	By	/s/ Peter
    Coker
	 	Name:	Peter Coker
     
	 	Title:	Sole Officer

 

	 

        
	DR.
    RAOUF GUIRGUIS
	 	
	 
	Signature:
    /s/ Raouf Guirguis                          

 

 

 

10Exhibit 4.3

 

Alcobra
Ltd.

 

The 2010 Incentive Option Plan

 

 

		1.	PURPOSE OF THE PLAN

 

The purpose of this 2010 Incentive
Option Plan (the “Plan”) is to advance the interests of Alcobra Ltd. (the “Company”) and
its shareholders by attracting and retaining the best available personnel for positions of substantial responsibility, providing
additional incentive to employees, office holders and service providers and promoting a close identity of interests between those
individuals and entities and the Company.

 

		2.	DEFINITIONS

 

As used
herein, the following definitions shall apply:

		2.1.	"Administrator" means the Board or the Committee, as shall administer the Plan,
as set forth herein.

		2.2.	“Articles” mean the Company’s Articles of Association, as amended from
time to time.

		2.3.	"Board" means the Board of Directors of the Company.

		2.4.	"Committee" means the Company’s compensation committee, or in the case there
is no such committee, a committee appointed in order to administer the Plan, and until such committee is appointed, the Board.

		2.5.	“Companies Law” means the Israeli Companies Law 5759 - 1999.

		2.6.	"Employee" means: (I) any person, employed by the Company or employed by any Related
Entity; and (II) any Office Holder (as such term is defined in the Companies Law), officer or Director of the Company or a Related
Entity.

		2.7.	“Exercise Price” means the price that is to be paid in order to exercise an
Option.

		2.8.	“Group” means the Company and the Related Entities taken together.

		2.9.	“IPO” means an initial public offering of the Company's Shares.

		2.10.	"Option" means an option to purchase a Share according to the provisions of this
Plan.

		2.11.	“Option Grant” means a single grant of Options to a certain Participant as determined
by the Board or the Committee.

 

    	 

    	-2-

    

 

		2.12.	"Option Grant Letter Agreement" means the notice letter attached to this Plan
as Exhibit A.

		2.13.	"Participant" means a person or entity that has been granted Options.

		2.14.	“Related Entity” means any parent or subsidiary of the Company. In addition,
Related Entity shall include any business, corporation, partnership, limited liability company or other entity in which the Company,
or the Company’s parent or a subsidiary holds a substantial ownership and/or interest, directly or indirectly, and is determined
by the Board to be a Related Entity.

		2.15.	“Service Provider” means a person or entity who is engaged by the Company or
any Related Entity to render services (e.g., consulting services, advisory services, development services, marketing and sale services
or any other services, including suppliers) to the Company or a Related Entity.

		2.16.	"Share" means the Company’s Ordinary Share of NIS 0.01 par value, or that
was issued following an exercise of an Option.

		2.17.	“Total Option Amount” means the amount of Options granted to a Participant in
a single Option Grant.

 

		3.	ADMINISTRATION OF THE PLAN

 

		3.1.	Subject to the provisions of the Plan, any applicable law, the Articles and any other binding commitments
taken by the Company, the Board or the Committee shall have the power and authority to administer the Plan. Such power and authority
shall include, but not be limited to: (i) approval of Option Grants and the determination of the terms and provisions of
respective Option Grants, including, the vesting schedules of the Options; the Exercise Price thereof; provisions concerning the
time or times when and the extent to which Options may be exercised; the nature and duration of restrictions as to transferability;
or any other special conditions relating to an Option Grant; (ii) the acceleration of any Participant’s right to exercise
Options, in whole or in part; (iii) the interpretation of the provisions of the Plan; (iv) altering, amending or rescinding any
resolution or act previously taken by the Committee; and (v) the determination of any other matter which is necessary or desirable
for, or incidental to, the administration of the Plan, as set forth in the Plan.

		3.2.	Notwithstanding the above, the Board shall have the power and authority to take any act the Committee
is empowered and authorized to take, and to alter amend or rescind any act or resolution taken by the Committee.

 

    	 

    	-3-

    

 

		3.3.	The Committee shall consist of such number of directors as may be appointed by the Board.

		3.4.	The Board shall have the exclusive discretion and power to grant Options. Such power may be delegated
by the Board to the Committee subject to the provisions of the Companies Law.

		3.5.	All Committee resolutions and decisions, including the interpretation and construction of any provision
of the Plan, shall be final and conclusive unless otherwise determined by the Board.

		3.6.	No member of the Board or of the Committee shall be held liable for any act or determination made
in good faith with respect to the Plan or any Option Grant.

 

		4.	SHARES RESERVED FOR THE PLAN

 

		4.1.	Subject to adjustments, as set forth in Section 9 below, a total of 2,118,531 Ordinary Shares,
of NIS 0.01 par value each, from the Company’s authorized share capital shall be reserved and subject to the Plan (the “Reserved
Shares”).

		4.2.	Until termination of the Plan the Company shall at all times reserve sufficient number of Ordinary
Shares in its authorized share capital to cover for all Reserved Shares that were not issued.

		4.3.	Without derogating from Section 4.2 above:

		4.3.1.	The Company need not reserve Shares with respect to Options that terminated, expired or were canceled
for any reason prior to exercise thereof.

		4.3.2.	In the case that there are certain Reserved Shares, which remain unissued and which are not subject
to outstanding Options, then the Board may resolve that such Reserved Shares shall cease to be reserved.

 

		5.	DESIGNATION OF PARTICIPANTS; OPTION GRANTS

 

		5.1.	The Board may grant Option Grants to the following persons and entities:

		5.1.1.	Employees.

		5.1.2.	Service Providers and their employees.

		5.2.	Unless determined otherwise by the Board or Committee, a Participant shall not be required to pay
any consideration for an Option Grant.

 

    	 

    	-4-

    

  

		6.	VESTING; EXERCISE PERIOD 

 

		6.1.	Unless determined otherwise by the Committee or Board, upon approval of the Option Grant or thereafter,
Options underlying an Option Grant shall vest over four years, commencing on the vesting commencement date (the "Vesting
Commencement Date") as determined by the Committee.

		6.2.	The vesting schedule of each Option Grant shall be as determined by the Committee. However, unless
determined otherwise by the Committee or Board, upon approval of the Option Grant or thereafter, the following shall apply:

25% of the
Total Option Amount shall vest on the first anniversary of the Vesting Commencement Date, and additional 6.25% of the Total Option
Amount shall vest on the last day of each three months period immediately after the first anniversary of the Vesting Commencement
Date.

In the case
that as a consequence of the vesting schedule mentioned above a fraction of vested Option is created, then such fraction shall
be rounded up or down, as determined by the Board.

		6.3.	Notwithstanding anything to the contrary in this Plan, all Options shall terminate and not bestow
any rights on their owner after ten years from the date the Options were granted. All Options that have not been exercised by such
date shall expire immediately and the Participants shall not have any claim against the Company with respect thereto.

		6.4.	The period within which Options are exercisable shall be called the “Exercise Period”.
Options which have not been exercised during the Exercise Period shall expire immediately, and will be automatically returned to
the Options pool and may be re-allocated.

 

		7.	TERMINATION OF EMPLOYMENT WITH THE GROUP 

 

In the event
that the Participant is an Employee at the time of the Option Grant, whose employment with the Group was subsequently terminated,
for whatever reason but subject to Section 7.6 (including but not limited to (i) dismissal of a Participant or (ii) a Participant’s
resignation, or (iii) death of a Participant or (iv) disability of a Participant), then the following provisions shall apply:

		7.1.	The date on which employment was terminated under applicable labor laws, or, in the case an Employee
is not an employee under applicable labor laws the date in which such Employee ceases to be an Employee as defined in the Plan,
shall be deemed the date in which such Employee’s employment was terminated (“Employment Termination Date”).

		7.2.	On the Employment Termination Date all Options that are not vested shall immediately expire.

 

    	 

    	-5-

    

 

		7.3.	In the event that the Participant's termination of employment is not due to the Participant's death
(but does include termination due to Disability), then the Participant will be entitled to exercise all, or part of, the vested
Options that have not expired, for a period of thirty (30) days after the Employment Termination Date. After such thirty days period,
all unexercised Options will automatically expire.

For purposes
of this Section 7.3, "Disability" shall mean the inability in 100%, due to illness or injury, to engage in any gainful
occupation for which the individual is suited by education, training or experience, which condition continues for at least six
(6) months.

		7.4.	Notwithstanding the above, in the event of termination of employment due to the Participant's death
or Disability, the Participant (if applicable) or Participant's estate, or other person who acquired the right to exercise the
Options by way of bequest or inheritance, may, but only within six (6) months after the date of such death or the Employment Termination
Date (in the case of Disability), exercise all, or part of, the vested Options that have not expired. After such six (6) months
period, all unexercised options shall automatically expire.

		7.5.	Notwithstanding Section 7.3 above, all Options granted to a certain Employee (whether vested or
unvested) will immediately expire if the termination of the Participant’s employment is due to Participant’s breach
of his/her employment agreement (whether written or oral) including without limitation, a breach of non compete obligations, or
breach of his/her fiduciary duties towards the Company or a Related Entity as determined by the Committee or the Board, in their
sole discretion, or in the case that competent court or other authority resolves that such employee is not entitled to discharge
compensation.

		7.6.	For the purposes of this Plan, the Committee or Board is authorized to determine if and when a
Participant terminated his/her employment with the Company, and due to what reason, subject to the provisions of Israeli labor
laws with respect to Israeli employees.

		7.7.	The Committee or the Board shall be entitled, prospectively and retroactively, to extend the periods
in which Options (either vested or unvested) do not expire and remain exercisable after the Employment Termination Date.

 

		8.	TERMINATION OF ENGAGEMENT WITH THE GROUP 

In the event that a Participant
is not an Employee, and the agreement of such Participant with the Group is terminated, then, unless otherwise specified in the
Option Grant Letter Agreement, or otherwise determined by the Committee, on the date of such termination, all Options that have
not vested by then shall expire and the vested options shall remain exercisable as specified in sections 7.3, 7.4 or 7.5, as the
case may be, which shall apply mutatis mutandis to such Participant (where if such Participant has more than one agreement
with the Group, then the foregoing shall apply to the Options underlying the terminated agreement or issued in connection therewith).

 

    	 

    	-6-

    

 

		9.	ADJUSTMENTS 

 

		9.1.	Merger, Sale of the Company or Sale of the Company’s Assets.

In the event
of a merger of the Company into another corporation, in a way that the Company shall no longer continue to exist as a legal entity
subsequent to such merger, the sale of all, or substantially all of the Company’s issued and outstanding shares to a third
party or the sale of all, or substantially all of the assets of the Company (each of them, a “Transaction”),
then the following provisions shall apply:

		9.1.1.	Each outstanding Option shall be assumed by, or an equivalent option shall be substituted by the
successor corporation or a parent or subsidiary of the successor corporation.

		9.1.2.	In the event that the successor corporation does not agree to assume the Options or to substitute
them with equivalent options, the Committee may in lieu of such assumption or substitution, provide for the Participant to have
the right to exercise the Options as to all, or part of the Shares, including certain Shares as to which it would not otherwise
be exercisable.

		9.1.3.	In addition to Section 9.1.2 above, and if Section 9.1.1 does not apply, the Committee may notify
the Participants that all Options that are exercisable shall remain so for a period of no less then seven (7) days from the date
of such notice, and that all Options will terminate upon the expiration of such period. In any case, the Committee may condition
the termination of all said Options upon consummation of the Transaction.

		9.2.	Bonus Shares

In the event
that the Company issues any of its shares as bonus shares to all its shareholders, on a pro rata basis, then the number of Shares
received upon exercise of certain Options shall be increased to the number of Shares the Participant would have held after the
issuance of the bonus shares had such Participant exercised such Options immediately before the issuance of the bonus shares.

		9.3.	Reorganization; Separation

If the Company
is separated, reorganized, or consolidated with another corporation (other than as part of a Transaction) while Options which were
not yet exercised remain outstanding under this Plan, the Company shall use reasonable efforts to maintain the rights of each Participant
through such separations, reorganizations or consolidations, or compensate the Participant for such event in lieu of the Options
such Participant holds. The Committee, at its sole discretion, shall determine what steps shall be taken according to this section
9.3.

 

    	 

    	-7-

    

 

		9.4.	Changes in Capitalization

If the outstanding
shares of the Company shall at anytime be changed or exchanged by declaration of a share split, reverse share split, combination
or reclassification of Ordinary Shares, or any other increase or decrease in the number Company’s Ordinary Shares effected
without receipt of consideration by the Company from the shareholders, then the number, class and kind of Shares subject to this
Plan or subject to any Options therefore granted, and the Exercise Prices of the Options, shall be appropriately and equitably
adjusted so as to maintain the proportionate number of Shares without changing the aggregate Exercise Prices of the Options (except
in case the Exercise Price is equal to the par value of the shares, in which case the Exercise Price will be increased respectively).
However no adjustment shall be made by reason of the distribution of subscription rights on outstanding shares, or conversion of
securities into shares of the Company.

		9.5.	Other terms and conditions

		9.5.1.	The allocation of each Option Grant hereunder is subject to the relevant Participant’s agreement
to sign any document he/she is required to sign pursuant to the provisions of this section 9. If a Participant refuses to sign
any such documents, the Committee or Board may determine that the Options held by the Participant or by a trustee for such Participant’s
benefit shall immediately expire.

		9.5.2.	Such adjustments as mentioned in this Section 9 shall be made by the Committee, whose determination
in such respect shall be final, binding and conclusive.

		9.5.3.	Anything herein to the contrary notwithstanding, if prior to an IPO, there is a bona fide offer
to purchase all or substantially all of the issued and outstanding shares of the Company, or upon a reorganization separation or
the like, all or substantially all of the shares of the Company are to be exchanged for securities of another company, then each
Participant shall be obliged to sell or exchange (in accordance with the value of such Participant’s Options and Shares pursuant
to the terms of such transaction) as the case may be, any Shares such Participant purchases hereunder, in accordance with the instructions
issued by the Board in connection with such transaction, which will be given according to a policy of the Board concerning all
of the Participants under the Plan.

 

		10.	ASSIGNABILITY AND SALE OF OPTIONS

 

No Option
shall be assignable, transferable, given as collateral, hypothecated pledged or encumbered and no right with respect to the Options
shall be given to any third party whatsoever, and during the lifetime of each Participant, each and all of such Participant’s
rights to purchase Shares hereunder shall be exercisable only by such Participant.

 

    	 

    	-8-

    

 

		11.	TERM AND EXERCISE OF OPTIONS

 

		11.1.	Options shall be exercised by a Participant by giving written notice to the Company, in the form
substantially attached hereto as Exhibit B or such other form(s) and method as may be determined by the Company from
time to time (the “Exercise Notice”).

		11.2.	The Exercise Price shall be payable upon the exercise of the Option in cash or by check, or other
form satisfactory to the Committee.

		11.3.	The Exercise Price will be paid in NIS, or if the Exercise Price is fixed in U.S. dollars, in U.S.
dollars or in accordance with the representative rate of exchange of the U.S. dollar, last published by the Bank of Israel at the
time of actual payment, or as provided for by the Company.

		11.4.	Each Participant will be entitled to exercise, upon signing the Exercise Notice and any additional
documents as required by the Company, and paying the Exercise Price, all, or part of the Options that are vested at the Exercise
Period.

		11.5.	Options shall not be deemed exercised unless: (I) the Company receives duly signed Exercise Notice
including all relevant details; and (II) the Company receives the Exercise Price.

		11.6.	The Options may be exercised only to purchase whole Shares, and in no case may a fraction of a
Share be purchased. If any fractional Shares would be deliverable upon exercise, such fraction shall be rounded up or down, to
the nearest whole number. Half of a Share will be rounded up.

		11.7.	Each Option granted under this Plan shall be exercisable during the Exercise Period. Subject to
adjustments, as set forth in Section 9 above, the exercise of one Option shall entitle the Participant to hold one Share.

		11.8.	Without derogating from any restrictions mentioned hereinabove, the exercise of the Options is
being subject to the following terms, restrictions and conditions as may be in effect on the time of the exercise of the Options
is requested: (i) any applicable law or regulation; (ii) any order or limitation set by any stock exchange in which the Company’s
securities may be traded (e.g., blackout periods, and lock up after an IPO); and (iii) any limitation undertaken by the Company
with respect of the shares of the Company, including limitations set forth by Company’s underwriters. Such period of restriction
of sale or exercise shall not be counted as part of the applicable exercise period.

 

    	 

    	-9-

    

 

		11.9.	Notwithstanding the foregoing, starting as of the Employment Termination Date of a certain Participant
and during the period that the vested Options are exercisable, the Company shall be entitled (subject to the provisions of applicable
law) to purchase the vested Options held by such Participant by sending the Participant a purchase notice (the "Purchase
Notice"). The purchase price of each Option shall be the Market Value of an Ordinary Share less the Exercise Price of
the Option. The Market Value of an Ordinary Share shall be determined as follows: (i) in case the Company's shares are listed on
a stock exchange, the Market Value shall be the average price of the Shares during 5 days prior to the Purchase Notice; or (ii)
in case the Company's shares are not traded, the Market Value shall be the value determined in good faith unanimously by the Board
and in the event the Board members are unable to reach an agreement with respect to the Market Value within 10 days of the
Purchase Notice to the Participant, the Board will refer to an external expert. The Committee or the Board shall be entitled
to establish further processes for the purchase of the Options as set forth above, provided, however, that if the Company receives
the Participant’s Exercise Notice prior to the receipt of the Purchase Notice from the Company, then the Company’s
right to purchase the said Options shall become null and void and the Participant may exercise the vested Options pursuant to their
terms.

 

		12.	RIGHTS AND OBLIGATIONS ATTACHED TO THE SHARES

 

		12.1.	No Participant shall have any of the rights or privileges of a shareholder of the Company with
respect to any of the Shares, unless and until, following exercise, the registration of the Participant as holder of such Shares
in the Company’s register of members is duly completed.

		12.2.	The rights and obligations attached to the Shares will be as set forth in the Articles. The Shares
may be subject to rights of first refusal, co-sale rights and other rights specified in the Articles.

		12.3.	The Participant waives any of the following rights to the extent such rights are attached to the
Shares: (i) pre-emptive rights in relation to issuance of new securities in the Company; (ii) rights of first refusal in relation
with any sale of shares of the Company; (iii) co-sale rights in relation with any sale of shares of the Company.

		12.4.	Unless provided otherwise by the Committee, until an IPO, all voting rights, and rights to receive
information from the Company with respect to the Shares shall be granted to the Board or as determined by the Board, in accordance
with Exhibit C attached hereto.

 

    	 

    	-10-

    

 

		12.5.	Without derogating from any restrictions mentioned hereinabove, by accepting an Option Grant, each
Participant agrees that the sale or disposal of Shares is subject to the following terms, restrictions and conditions as may be
in effect on the time when such sale or disposal is requested: (i) any applicable law or regulation; (ii) any order or limitation
set by any stock exchange in which the Company’s securities may be traded (e.g., blackout periods, and lock up after an IPO);
and (iii) any limitation undertaken by the Company with respect of the shares of the Company, including limitations set forth by
Company’s underwriters.

		12.6.	Until an IPO the Company shall have the authority to endorse upon the certificate or certificates
representing the Shares such legends referring to the foregoing restrictions, and any other applicable restrictions, as it may
deem appropriate (and which do not violate the Participant's rights according to this Agreement).

		12.7.	By accepting an Option Grant, each Participant agrees that in the case of an IPO or after registering
the Company’s securities for trading, to sign any document and approve any resolution or restriction upon the Shares, or
modify the terms of allocation of the Shares, if such Participants signature or approval or such restriction or modification were
reasonably required, in the Committee’s discretion, in order to facilitate the Company in meeting all the underwriters and
stock exchange demands and all applicable securities and corporate laws and regulations.

		12.8.	The Participant shall not sell, pledge, transfer or otherwise dispose of any Shares in transactions
which violate, according to the Company’s sole discretion, any applicable laws, rules and regulations, or the Articles.

		12.9.	No transfer of Shares shall be effective if the Committee determines that the transferee is a competitor
of the Company (either directly or indirectly).

		12.10.	Notwithstanding anything to the contrary in this Section 12, as long as Shares are held by a trustee
for the benefit of a Participant (if applicable) the Shares shall not be sold, pledged, transferred or otherwise disposed of, by
the Participant until an IPO, or until such time or event as determined by the Committee, either individually or with respect to
all Participants.

 

		13.	TERM OF THE PLAN

 

This Plan shall be effective
as of January 1, 2010, which is the day it was adopted by the Board and shall terminate when all the Options are exercised into
Shares or expired in accordance with the provisions of this Plan or such other date as shall be determined by the Board, which
date shall be no later than January 1, 2020.

 

    	 

    	-11-

    

 

		14.	AMENDMENTS; TERMINATION

 

		14.1.	The Board may, at any time and from time to time, amend, alter or terminate the Plan, provided,
however, that the rights of the Participants shall not be adversely affected, unless such Participants agreed to such amendment,
alteration or termination.

		14.2.	The Plan may be terminated at any time by an action of the Board, but any such termination will
not terminate any Options granted under this Plan, which are then outstanding, without the consent of the Participant that is holding
such Options.

 

		15.	BINDING EFFECT

 

The provisions of the Plan
shall be binding upon the heirs, executors, administrators, and successors of the Participants.

 

		16.	GOVERNMENT REGULATIONS AND OTHER RESTRICTIONS

 

		16.1.	This Plan, the Option Grant Letter Agreements, the grant and exercise of Options hereunder, the
obligation of the Company to issue the Shares, and any other act or obligation of the Company or any related individual or entity
acting in connection with this Plan are all subject to the Articles, all applicable laws, rules, and regulations, whether of the
State of Israel or of the United States or any other state having jurisdiction over the Company and any Participant.

		16.2.	By accepting an Option Grant, each Participant agrees not to sell, pledge, transfer or otherwise
dispose of any of the Shares such Participant may hold except in compliance with: (I) the United States Securities Act of 1933,
as amended, and the rules and regulations thereunder if applicable; and (II) the Israeli Securities Law 5728 – 1968; and
(III) any other applicable securities law, regulations or other rules set by any stock exchange in which the Company's securities
may be traded; and to further agree that certificates evidencing any of such Shares shall bear appropriate legend to reflect such
restrictions. The Company does not obligate itself to register any shares under the United States Securities Act of 1933, as amended
or any other securities laws.

 

		17.	TAX CONSEQUENCES, INDEMNIFICATION

 

		17.1.	Any tax consequences (pursuant to Israeli or any other applicable law that the relevant Participant
is subject to), including tax consequences due to adjustments, made in accordance with Section 9 above, arising from the grant
or exercise of any Option, the payment for Shares covered thereby, or any other event or act (of the Company or any Participant)
relating to the Plan, shall be borne solely by each Participant.

 

    	 

    	-12-

    

 

		17.2.	The Company and/or the Board and/or the Committee and/or a trustee for the Plan shall not be required
to release any Share certificates or transfer any Shares to a Participant until all required tax payments have been fully made.

		17.3.	The Company may withhold taxes according to the requirements under the applicable laws, rules,
and regulations, including withholding taxes at source. In the case that applicable law requires so, the Company shall deduct taxes
at source. Such deduction may be made from any proceeds attributed to the exercise of the Options and sale of Shares, or from any
proceeds the Participant is entitled to receive from the Group or other proceeds such Participant owns and are held by the Group,
including from Participant’s salary or other proceeds he/she is entitled to receive from the Company or a Related Entity.
It is explicitly stated herein that each Participant who is an Employee, by accepting an Option Grant agrees to the deduction from
his/her salary of any amounts that in the Company’s determination are required to be deducted under applicable law in connection
with the Plan. In any such case, the Company shall be entitled
to offset any amounts due to such Participant on account of such taxes.

		17.4.	In the case that the Company, or any other person on its behalf is required to pay taxes, that
under applicable law should have been paid by the Participant, then such Participant shall immediately either pay such tax, or,
if such tax was already paid, reimburse the Company, or such other person for the total amount paid.

		17.5.	Neither the Company, nor any Related Entity nor anyone on their behalf, shall give, or be deemed
to be giving any Participant, or a potential Participant, advice regarding tax consequences relating to the Plan and issuance of
securities thereunder. Each Participant shall rely solely, while considering participation in the Plan, on the advice of such Participant’s
consultants.

 

		18.	CONTINUANCE OF EMPLOYMENT OR ENGAGEMENT

 

Neither the Plan nor any Option
Grant shall be construed to impose any obligation on any entity included in the Group to continue any Participant’s employment
with it (in the case that the Participant is an Employee) or to maintain any business engagement with such Participant. Nothing
in the Plan or in any Option Grant shall confer upon any Participant any right to continue to be employed by the Group or to maintain
any other business engagement with it, or restrict the right of any entity included in the Group to terminate such employment or
business engagement at any time.

 

    	 

    	-13-

    

 

		19.	RULES PARTICULAR TO SPECIFIC COUNTRIES

 

		19.1.	Notwithstanding anything herein to the contrary, the terms and conditions of the Plan may be amended
with respect to particular types of Participants as determined by the Board (for example, Israeli employees, employees that are
subject to US taxation) by an addendum to the Plan (the “Appendix”).

		19.2.	The Company may adopt one or more Appendixes. Each Appendix shall be approved by the Board and
as required or advisable under applicable law.

		19.3.	The terms of an Appendix shall govern only with respect to the types of Participants specified
in such Appendix.

		19.4.	In the case that the terms and conditions set forth in an Appendix conflict with any provisions
of the Plan, the provisions of the Appendix shall govern with respect to Participants that are subject to such Appendix, provided,
however, that such Appendix shall not be construed to grant the Participants rights not consistent with the terms of the Plan,
unless specifically provided in such Appendix.

 

		20.	NON-EXCLUSIVITY OF THE PLAN

 

		20.1.	The adoption of the Plan by the Board shall not be construed as amending, modifying or rescinding
any previously approved incentive arrangements or as creating any limitations on the power of the Board to adopt such other incentive
arrangements as it may deem desirable, including, without limitation, the granting of Options other than under this Plan, and such
arrangements may be either applicable generally or only in specific cases.

		20.2.	The grant of Options hereunder shall neither entitle the recipient thereof to participate, nor
disqualify him from participating in, any other grant of Options pursuant to this Plan or any other option or stock plan of the
Company.

 

		21.	MULTIPLE AGREEMENTS; OTHER CORPORATE ACTIONS

 

		21.1.	The terms of each Option Grant may differ from other Options Grants granted under the Plan at the
same time, or at any other time. The Board may also grant more than one Option Grant to a certain Participant during the term of
this Plan, either in addition to, or in substitution for, one or more Option Grants previously granted to such Participant.

 

    	 

    	-14-

    

 

		21.2.	Under no circumstances shall the Plan be construed to grant any right to a Participant, or any
other third party, to postpone, delay or affect any corporate action resolved by the Company.

 

		22.	GOVERNING LAW & JURISDICTION

This Plan shall be governed
by, construed and enforced in accordance with the laws of the State of Israel, without giving effect to the principles of conflict
of laws. Any dispute or claim shall be put to the Board’s resolution. Subject to the above, the competent courts of Tel-Aviv,
Israel shall have sole jurisdiction in any matter pertaining to this Plan, and any other issue related to it.

 

		23.	NO WAIVER

The failure of the Company
or any other party acting on its behalf or assisting it in implementing the Plan to enforce at any time any provisions of the Plan
shall not be construed to constitute a waiver of such provision or of any other provision hereof.

 

		24.	NOTICES

		24.1.	Any notice, request, demand or other communication required or permitted under the Plan shall be
in writing and shall be deemed to have been duly given, made and received only by personal delivery or if sent by certified mail,
postage prepaid, return receipt requested, overnight delivery service, facsimile transmission (with confirmation of delivery),
or confirmed e-mail to the address of the Company (if sent to the Company), or to the address of the Participant as such was provided
by him in the Option Grant Letter Agreement, unless such address is changed by written notice received by the Company.

		24.2.	Except as otherwise set forth herein, any notice sent by mail shall be deemed to be given six days
after deposit with the relevant post service; any notice sent by overnight delivery service shall be deemed given the first business
day after deposited with the delivery service; and any notice sent by facsimile transmission or e-mail, shall be deemed given when
transmitted if sent during normal business hours or if not, on the next business day; and any notice given by personal delivery
shall be deemed given on the date of delivery.

		24.3.	In the case a certain Participant changes his or her contact details, in a way that the contact
details provided to the Company by him do not enable the Company to provide notices and other communications to such Participant,
then such Participant shall be deemed to have waived his or her right to receive any notices, and the Committee shall have the
right, in its sole discretion, to take any appropriate action under the circumstances.

 

    	 

    	-15-

    

 

Appendixes

 

Appendix A: Terms of grant of options
to Israeli employees

 

Exhibits:

 

Exhibit A: Option Grant Letter Agreement

 

Exhibit B: Form of Exercise Notice

 

Exhibit C: Proxy

 

    	 

    	-16-

    

 

Appendix A

Terms of grant of Options
to Israeli employees

 

		1.	Purpose of the Appendix 

 

		1.1.	This Appendix (the “Appendix”) is made as part of the Plan (as defined herein
whereas all terms not otherwise defined herein shall have the meaning ascribed to them in the Plan) and pursuant to the provisions
of Section 102 of the Income Tax Ordinance (as defined herein).

		1.2.	This Appendix governs grants of Options to Israeli Employees, either by a Trustee, or without a
Trustee.

 

		2.	Definitions

 

As used
herein, the following definitions shall apply:

 

		2.1.	“Capital Gain Method” means choosing the alternative of capital gain method
under Section 102.

		2.2.	“Eligible Participant” means any employee as such term is defined in Section
102. Without derogating from the foregoing Eligible Participant shall include any employee or Office Holder (as such term is defined
in the Companies Law) of the Company or any Subsidiary except for such persons that are deemed to be ‘Ba’al Shlita’
under Section 32 to the Income Tax Ordinance.

		2.3.	"Deposit Date" means the date in which options were deposited with the Trustee
for the benefit of a certain Participant.

		2.4.	“Income Tax Authorities” mean the Israeli income tax authorities that are authorized
to give approvals in relation with this Appendix and Option Grants to Eligible Participants.

		2.5.	“Income Tax Ordinance” means the Israeli Income Tax Ordinance (New Version)
1961, as amended from time to time.

		2.6.	“Labor Income Method” means choosing the alternative of labor income method
under Section 102.

		2.7.	“Participant” means any Eligible Participant who is granted with Options.

		2.8.	“Plan” means the 2010 Incentive Option Plan this Appendix is attached to.

		2.9.	“Realization Event” means, with respect to each Option Grant granted to a certain
Participant, the earlier to occur of: (I) transfer of Securities from the Trustee to such Participant; or (II) the sale of Shares
by the Trustee; or (III) one day before such Participant is no longer an Israeli resident (as provided for in Section 100A to the
Income Tax Ordinance).

 

    	 

    	-17-

    

 

	 	2.10.	“Release
    Term” means: (i) in the case of Capital Gains Method, a period ending twenty four (24) months after the Deposit
    Date; (ii) In the case of Labor Income Method ‘Release Term’ shall mean a period ending twelve (12) months after
    the Deposit Date.

 

	 	2.11.	“Section
    102” means Section 102 to the Income Tax Ordinance as amended from time to time, and / or as superseded and any
    rules regulations or instructions promulgated or enacted under such Section 102.

 

	 	2.12.	“Securities”
    mean Options subject to a certain Option Grant and Shares received subsequent exercise of such Options.

 

	 	2.13.	“Tax
    Method” means either Capital Gains Method or Labor Income Method.

 

	 	2.14.	“Trust”
    means a trust, maintained under the Trust Agreement entered into between the Company and the Trustee for administration of
    grant of Options under Section 102. 

 

	 	2.15.	“Trust
    Agreement” means the agreement between the Company and the Trustee as may be in effect from time to time specifying
    the duties and authorities of the Trustee.

 

	 	2.16.	“Trust
    Assets” mean all Securities and other assets held in Trust for the benefit of the Participants pursuant to this
    Appendix and the Trust Agreement

 

	 	2.17.	“Trustee”
    means  ESOP Trust Company Ltd. (and any successor Trustee) who was, or shall be appointed by the Board of Directors of the
    Company     and     approved     by the Income Tax Authorities to hold the Trust Assets.

 

		3.	Provisions of the Appendix shall govern

 

The provisions
of the Appendix shall supersede and govern in the case of any inconsistency or conflict arising between the provisions of the Appendix
and the provisions of the Plan, provided, however, that this Appendix shall not be construed to grant Participant rights not consistent
with the terms of the Plan, unless specifically provided herein.

 

		4.	Selection of Tax Method – Capital Gains Method

 

The Company
chooses the Capital Gain Method (‘Maslul Revach Hon’). This choice may be changed in the future, by a Board
resolution, provided, however, that the change in selection is permissible under the provisions of Section 102.

 

		5.	Holding of Securities by the Trustee 

 

		5.1.	All Securities shall be issued to the Trustee to be held in the Trust for the benefit of the relevant
Participants. All certificates representing Securities issued to the Trustee under this Appendix shall be deposited with the Trustee,
and shall be held by the Trustee until such time that such Options or Shares are released from the Trust as herein provided.

 

    	 

    	-18-

    

 

		5.2.	After the Release Term is over, a Participant shall be entitled to instruct the Trustee to transfer
the Shares held for such Participant’s benefit to such Participant, provided, however, that the Trustee confirms that all
applicable tax as set in Section 102 was actually paid and the Trustee holds a confirmation to that effect from Income Tax Authorities.

		5.3.	In the case that the Company distributes dividends, than the amount of dividends with respect of
Shares held in Trust shall be paid to the Participants that are the beneficial holders of such Shares, subject to deduction at
source of the applicable tax.

 

		6.	Provisions governing this Appendix and Plan 

 

Notwithstanding anything to
the contrary in the Plan or elsewhere in this Appendix:

 

		6.1.	The Plan shall have one, sole, Trustee.

		6.2.	The Appendix shall be subject to one Tax Method, unless the provisions of Section 102 allow otherwise.

		6.3.	The Participants shall not be entitled to cause a Realization Event to occur unless the Release
Term is fulfilled.

		6.4.	All rights or benefits that are received subsequent to the grant or exercise the Options or the
Shares underlying such Options (including and not limited to bonus shares) shall be deposited with the Trustee until the end of
the Release Term, and all such rights and benefits shall be subject to the Tax Method selected by the Company.

 

		7.	Effectiveness
of the Appendix

 

This Appendix
shall become effective, and Option Grants may be granted hereunder only after receipt the required approvals under Section 102
from the Income Tax Authorities.

 

		8.	Additional limitations 

 

		8.1.	The Company shall not issue Options to a Participant unless such Participant confirmed in writing
that he/she is aware of the provisions of Section 102 and the applicable Tax Method, and such Participant agreed in writing to
the terms of the Trust Agreement, and that he/she shall not cause a Realization Event to occur before the Release Term is over.
The form for the above confirmation shall be determined by the Committee, and shall be attached to the Plan as Exhibit A.

		8.2.	By accepting an Option Grant, each Participant agrees irrevocably to discharge the Trustee, the
Company and any other office holder, employee or agent thereof from any liability with respect of any action or decision duly taken
and bona fide executed in relation with the Plan, or relating to any Option Grant or Shares.

		8.3.	The Trustee shall use the voting rights vested in any such shares issued upon the exercise of any
Options granted under the Plan, in accordance with Exhibit C of the Plan.

 

		9.	Grant of Options not by a Trustee

 

Notwithstanding
the above, the Company shall be entitled to allocate Option Grants not according to the Tax Methods, but by direct grant to Participants,
provided, however, that the requirements of Section 102 are met.

 

    	 

    	-19-

    

 

ADDENDUM

 

Terms of Options granted
to United States

Employees and Service Providers

 

		10.	Purpose of the Addendum

 

This Addendum (also referred
to as the "Addendum") is part of the 2010 Incentive Option Plan of Alocbra Ltd. (the "Plan").
All terms not otherwise defined herein shall have the meaning ascribed to them in the Plan. This Addendum governs grants of Options
to United States Employees and other Service Providers.

 

		11.	Provisions of the Addendum 

 

The provisions of the Addendum
shall supersede and govern in the case of inconsistency between the provisions of the Addendum and the provisions of the Plan,
provided, however, that this Addendum shall not be construed to grant to any Participant rights not consistent with the terms of
the Plan, unless specifically provided herein.

 

		12.	Eligibility

The individuals who shall be eligible to receive Option Grants under the Plan that are subject to the provisions of this Addendum
shall be employees, directors and other individuals and entities who are United States citizens or who are resident aliens of the
United States for United States federal tax purposes (collectively, “U.S. Persons”), and who render services
to the management, operation or development of the Company or a Subsidiary and who have contributed or may be expected to contribute
materially to the success of the Company or a Subsidiary. ISOs (as defined in Section 4 below) shall not be granted to any individual
who is not an employee of a corporation for United States federal tax purposes. The term “Subsidiary” as used
in this Addendum means a corporation or other business entity of which the Company owns, directly or indirectly through an unbroken
chain of ownership, fifty percent or more of the total combined voting power of all classes of stock.

 

4.Terms
and Conditions of Options

 

Every Option
granted to a U.S. Person shall be evidenced by a written stock option agreement (the "Stock Option Agreement")
in such form as the Committee shall approve from time to time, specifying the number of Shares that may be purchased pursuant to
the Option, the time or times at which the Option shall become exercisable in whole or in part, whether the Option is intended
to be an incentive stock option (“ISO”) or a nonqualified stock option (“NSO”) and such other
terms and conditions as the Committee shall approve, and containing or incorporating by reference the following terms and conditions.
The Plan and this Addendum shall be administered in such a manner as to permit those Options granted hereunder and specially designated
as an ISO to qualify as incentive stock options as described in Section 422 of the Internal Revenue Code of 1986, as amended (the
“Code”).

 

    	 

    	-20-

    

 

(a)
Duration. Each Option shall expire no later than ten (10) years from its grant date; provided, however, that no ISO granted
to an Employee who owns (directly or under the attribution rules of Section 424(d) of the Code) stock possessing more than ten
percent of the total combined voting power of all classes of stock of the Company or any Subsidiary shall expire later than five
(5) years from its date of grant.

 

(b)
Exercise Price. The exercise price of each Option shall be as specified by the Committee in its discretion; provided, however,
that the price shall be at least 100 percent of the Fair Market Value (as hereinafter defined) of the Shares on the date on which
the Board grants the Option (or shareholders resolution to grant such options, if such resolution is required), which shall be
considered the date of grant of the Option for purposes of fixing the price; and provided, further, that the price with respect
to an ISO granted to an Employee who at the time of grant owns (directly or under the attribution rules of Section 424(d) of the
Code) stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or of any Subsidiary
shall be at least 110 percent of the Fair Market Value of the Shares on the date of grant of the ISO. For purposes of the Plan,
except as may be otherwise explicitly provided in the Plan or in any Stock Option Agreement, the “Fair Market Value”
of a Share at any particular date shall be determined according to the following rules: (i) if the Shares are not at the time listed
or admitted to trading on a stock exchange, the Fair Market Value shall be the closing price of the Shares on the date in question
in the over-the-counter market, as such price is reported in a publication of general circulation selected by the Board and regularly
reporting the price of the Shares in such market; provided, however, that if the price of the Shares is not so reported, the Fair
Market Value shall be determined in good faith by the Board, which may take into consideration (1) the price paid for the Shares
in the most recent trade of a substantial number of shares known to the Board to have occurred at arm’s length between willing
and knowledgeable investors, (2) an appraisal by an independent party or (3) any other method of valuation undertaken in good faith
by the Board, or some or all of the above as the Board shall in its discretion elect; or (ii) if the Shares are at the time listed
or admitted to trading on any stock exchange, then the Fair Market Value shall be the last known closing price of the Shares when
the relevant Option Grant is approved by the Company. Notwithstanding Subsection (ii) above, the Administrator may adopt any other
method in order to determine the Fair Market Value of a Share, as long as use of such method will not give rise to adverse tax
consequences under Internal Revenue Code Section 409A. 

 

(c)Notice
of ISO Stock Disposition. The Participant must notify the Company promptly in the event that he sells, transfers, exchanges
or otherwise disposes of any Shares issued upon exercise of an ISO before the later of (i) the second anniversary of the date of
grant of the ISO or (ii) the first anniversary of the date the shares were issued upon his exercise of the ISO.

 

    	 

    	-21-

    

 

(d)Effect
of Cessation of Employment or Service Relationship. The Committee shall determine in its discretion and specify in each Stock
Option Agreement the effect, if any, of the termination of the Participant’s employment with or performance of services for
the Company or any Subsidiary on the exercisability of the Option.

 

(e)No
Rights as Stockholder. A Participant shall have no rights as a stockholder with respect to any Shares covered by an Option
until the date of issuance of a stock certificate to him for the Shares. No adjustment shall be made for dividends or other rights
for which the record date is earlier than the date the stock certificate is issued, other than as required or permitted by the
Plan.

 

(f)Transferability
of Options. Except as permitted by the Committee, and set forth in the terms of a Participant’s Stock Option Agreement,
an Option shall not be assignable or transferable by the Participant except by will or by the laws of descent and distribution.
During the life of the Participant, an Option shall be exercisable only by him, by a conservator or guardian duly appointed for
him by reason of his incapacity or by the person appointed by the Participant in a durable power of attorney acceptable to the
Company’s counsel.

 

		5.	Requirements
of Law

 

		(a)	The Company shall not be required to transfer Shares or to sell or issue any Shares upon the exercise
of any Option if the issuance of such Shares will result in a violation by the Participant or the Company of any provisions of
any law, statute or regulation of any governmental authority. Specifically, in connection with the Securities Act of 1933, as amended
from time to time (the “Securities Act”), upon the exercise of any Option, the Company will not be required
to issue Shares unless the Committee has received evidence satisfactory to it to the effect that the holder of the Option will
not transfer such shares except pursuant to a registration statement in effect under the Securities Act or unless an opinion of
counsel satisfactory to the Company has been received by the Company to the effect that registration is not required. Any determination
in this connection by the Committee shall be conclusive. The Company shall not be obligated to take any other affirmative action
in order to cause the exercise of an Option to comply with any law or regulations of any governmental authority, including, without
limitation, the Securities Act or applicable state securities laws.

 

		(b)	All other provisions of this Addendum and the Plan notwithstanding, this Addendum and the Plan
shall be administered and construed so as to avoid any person who receives an Option Grant incurring any adverse tax consequences
under Internal Revenue Code Section 409A. The Administrator shall suspend the application of any provisions of the Plan which could,
in its sole determination, result in an adverse tax consequence to any person under Internal Revenue Code Section 409A.

 

    	 

    	-22-

    

 

		6.	Forfeiture for Dishonesty or Termination for Cause 

 

Notwithstanding
any provision of the Plan to the contrary, if the Committee determines, after full consideration of the facts, that:

 

(a)
the Participant has been engaged in fraud, embezzlement, theft or commission of a felony in the course of his or her employment
by or involvement with the Company, a Subsidiary or a parent corporation as defined in Section 424 of the Code or any direct or
indirect subsidiary of such parent (an “Affiliate”) or has made unauthorized disclosure of trade secrets or
other proprietary information of the Company, a Subsidiary, an Affiliate or of a third party who has entrusted such information
to the Company, a Subsidiary or an Affiliate; or

 

(b)
the Participant has violated the terms of any employment, noncompetition, nonsolicitation or proprietary information agreement
to which he is a party; or

 

(c)
the Participant’s employment or involvement with the Company, a Subsidiary or an Affiliate was terminated for “cause,”
as defined in any employment agreement with the Participant, if applicable, or if there is no such agreement, as determined by
the Committee, which may determine that “cause” includes among other matters the willful failure or refusal of the
Participant to perform and carry out his or her assigned duties and responsibilities diligently and in a manner satisfactory to
the Committee;

 

then the Participant’s
right to exercise an Option shall terminate as of the date of such act (in the case of (a) or (b)) or such termination (in the
case of (c)), the Participant shall forfeit all unexercised Options and shall be required to sell to the Company or, in the case
the Company is not allowed to repurchase its own shares, to a third party approved by the Company, all or any part of the Shares
acquired by the Participant prior to such event, at a price equal to the lesser of their Fair Market Value or the amount paid to
the Company upon such transfer or exercise. If a Participant whose behavior the Company asserts falls within the provisions of
(a), (b) or (c) above has exercised or attempts to exercise an Option prior to consideration of the application of this Section
6 or prior to a decision of the Committee, the Company shall not be required to recognize such exercise until the Committee has
made its decision and, in the event any exercise shall have taken place, it shall be of no force and effect (and shall be void
ab initio) if the Committee makes an adverse determination, provided, however, that if the Committee finds in favor
of the Participant then the Participant will be deemed to have exercised the Option retroactively as of the date he or she originally
gave notice of his or her attempt to exercise or actual exercise, as the case may be. The decision of the Committee as to the cause
of a Participant’s discharge and the damage done to the Company shall be final, binding and conclusive. No decision of the
Committee, however, shall affect in any manner the finality of the discharge of such Participant by the Company. For purposes of
this Section 6, reference to the Company shall include any Subsidiary or Affiliate.

 

		7.	Tax Withholding 

 

To the extent required by law,
the Company may withhold or cause to be withheld income and other taxes with respect to any income recognized by a Participant
by reason of the exercise of an Option, and as a condition to the receipt of any Option the Participant shall agree that if the
amount payable to him by the Company and any Subsidiary in the ordinary course is insufficient to pay such taxes, then he shall
upon the request of the Company pay to the Company an amount sufficient to satisfy its tax.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]